Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure

被引:175
作者
La Rocca, HPB [1 ]
Esler, MD [1 ]
Jennings, GL [1 ]
Kaye, DM [1 ]
机构
[1] Alfred Hosp, Alfred & Baker Med Unit, Baker Med Res Inst, Melbourne, Vic, Australia
关键词
heart failure; noradrenaline; sympathetic nervous system; prognosis; sudden death;
D O I
10.1053/euhj.2000.2407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To investigate whether strong cardiac sympathetic activity contributes primarily to sudden death or to worsening heart failure, and to determine the relationship of the size of cardiac noradrenaline stores to the mode of death. Methods and Results The study population comprised 116 patients with congestive heart failure (ejection fraction 19 +/- 7%) and a mean follow-up of 18 +/- 19 months. Cardiac sympathetic nervous function was measured using coronary sinus blood sampling and noradrenaline isotope dilution methodology. Cardiac sympathetic activity was estimated from cardiac noradrenaline spillover, and noradrenaline stores from the overflow of the tritiated noradrenaline metabolite [H-3]dihydroxyphenylglycol, which is produced by monoamine oxidase inside nerve endings. Small cardiac noradrenaline stores (below median) predicted death from worsening heart failure (hazard ratio = 4.18, P<0.05), particularly if cardiac noradrenaline spillover was elevated (hazard ratio = 2.36 per tertile, P<0.01), indicating progression of disease associated with defective sympathetic innervation. In contrast,large stores (hazard ratio = 2.81, P<0.05). especially if coupled with increased noradrenaline spillover (hazard ratio = 1.64 per tertile, P<0.05), were related to sudden death. Conclusion High cardiac sympathetic activity is a risk factor for sudden death. particularly in the presence of intact cardiac sympathetic innervation. Conversely, progression of myocardial disease and heart failure is closely associated with depletion of sympathetic nerves in the heart, especially if rates of noradrenaline release paradoxically remain high.
引用
收藏
页码:1136 / 1143
页数:8
相关论文
共 42 条
[1]   Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation [J].
Aaronson, KD ;
Schwartz, JS ;
Chen, TM ;
Wong, KL ;
Goin, JE ;
Mancini, DM .
CIRCULATION, 1997, 95 (12) :2660-2667
[2]  
BINAH O, 1992, CIRCULATION, V85, P25
[3]   DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].
BRISTOW, MR ;
GINSBURG, R ;
MINOBE, W ;
CUBICCIOTTI, RS ;
SAGEMAN, WS ;
LURIE, K ;
BILLINGHAM, ME ;
HARRISON, DC ;
STINSON, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211
[4]   BETA-ADRENOCEPTORS IN CARDIAC DISEASE [J].
BRODDE, OE .
PHARMACOLOGY & THERAPEUTICS, 1993, 60 (03) :405-430
[5]   PLASMA NOREPINEPHRINE AS A GUIDE TO PROGNOSIS IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE [J].
COHN, JN ;
LEVINE, TB ;
OLIVARI, MT ;
GARBERG, V ;
LURA, D ;
FRANCIS, GS ;
SIMON, AB ;
RECTOR, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) :819-823
[6]   Medical therapy can improve the biological properties of the chronically failing heart - A new era in the treatment of heart failure [J].
Eichhorn, EJ ;
Bristow, MR .
CIRCULATION, 1996, 94 (09) :2285-2296
[7]   INCREASED CARDIAC PRODUCTION OF DIHYDROXYPHENYLALANINE (DOPA) DURING SYMPATHETIC-STIMULATION IN ANESTHETIZED DOGS [J].
EISENHOFER, G ;
SMOLICH, JJ ;
ESLER, MD .
NEUROCHEMISTRY INTERNATIONAL, 1992, 21 (01) :37-44
[8]   Cardiac sympathetic nerve function in congestive heart failure [J].
Eisenhofer, G ;
Friberg, P ;
Rundqvist, B ;
Quyyumi, AA ;
Lambert, G ;
Kaye, DM ;
Kopin, IJ ;
Goldstein, DS ;
Esler, MD .
CIRCULATION, 1996, 93 (09) :1667-1676
[9]  
EISENHOFER G, 1986, CLIN CHEM, V32, P2030
[10]  
EISENHOFER G, 1991, J LAB CLIN MED, V117, P266